Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena

Journal of Clinical Investigation

Volumn 108, Issue 3, 2001, Pages 349-355

  Iozzo, Renato V ^a,b   San Antonio, James D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROTEOHEPARAN SULFATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LYMPHOKINES; MODELS, CARDIOVASCULAR; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034904186     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113738     Document Type: Review

References (45)

1. Still more complexity in mammalian basement membranes
2. The elusive functions of proteoglycans: In vivo veritas
3. Functions of cell surface heparan sulfate proteoglycans
4. Matrix proteoglycans: From molecular design to cellular function
5. Glypicans
6. An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein
7. Heparan sulfate proteoglycans in basement membranes: Perlecan, agrin and collagen XVIII
8. Collagen XVIII/endostatin structure and functional role in angiogenesis
9. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells
10. Specificities of heparan sulphate proteoglycans in developmental processes
11. Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of wingless
12. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis
13. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factor
14. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action
15. Heparan sulfate proteoglycan isoforms of the CD44 hyalutonan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action
16. Fibroblast growth factor-2
17. Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response
18. FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: A compensation model for FGF-2 signaling
19. 165
20. The biology of perlecan: The multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices
21. Developmental expression of perlecan during murine embryogenesis
22. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA
23. Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA
24. Regulation by heparan sulfate in fibroblast growth factor signaling
25. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo
26. The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7
27. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope
28. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core
29. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors
30. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
31. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells
32. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan
33. Transcriptional silencing of perlecan gene expression by interferon-γ
34. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
35. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
36. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases
37. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
38. Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas
39. Endostatin inhibits VEGF-induced endothelial cell migration and rumor growth independently of zinc binding
40. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
41. Interaction of endostatin with integrins implicated in angiogenesis
42. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2
43. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity
44. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding
45. Cell surface glypicans are low-affinity endostatin receptors